Literature DB >> 20973909

Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy.

Roger Li1, Michael K Louie, Hak J Lee, Kathryn Osann, Donald L Pick, Rosanne Santos, Elspeth M McDougall, Ralph V Clayman.   

Abstract

OBJECTIVE: • To evaluate the safety and efficacy of 'tubeless' nephrostomy tract closure in reducing postoperative morbidity after percutaneous nephrolithotomy (PCNL).
MATERIALS AND METHODS: • In all, 31 patients undergoing PCNL were randomized into three groups, each with a different method of nephrostomy tract closure: using either a gelatin matrix haemostatic sealant (FloSeal), fascial stitch or Cope loop nephrostomy tube. • We compared operative time, estimated blood loss (EBL), postoperative stay, analgaesics use, changes in creatinine and haemoglobin levels, and stone clearance rate, as well as postoperative short-form (SF)-36 quality-of-life and pain analogue scores at five different time points after surgery. • All data were analysed using a one-way anova test. • A repeated measures anova test was used selectively to assess the progression of SF-36 and pain analogue scores.
RESULTS: • The preoperative variables operative time, EBL, postoperative stay (P = 0.45), analgaesia use (P = 0.79), changes in creatinine (P = 0.28) and haemoglobin (P = 0.09) levels, and postoperative SF-36 scores were not significantly different. • In contrast, the differences in analogue pain scales at 1 week after surgery (P = 0.02) and the trends of analogue pain score progression (P = 0.03) were statistically significant. • Three patients underwent second-look procedures for residual stones and there was one case of postoperative pyelonephritis in a multiple sclerosis patient.
CONCLUSIONS: • The Cope loop closure patients recovered fastest, while FloSeal closure patients experienced initial increase in pain followed by resolution at 1 month. • As a result of the small study group sizes, it is difficult to show any significant difference in postoperative pain, especially in long-term follow-up; further clinical evaluation is necessary.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20973909     DOI: 10.1111/j.1464-410X.2010.09676.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

1.  Current Status of Hemostatic Agents and Sealants in Urologic Surgical Practice.

Authors:  Sashi S Kommu; Robert McArthur; Amr M Emara; Utsav D Reddy; Christopher J Anderson; Neil J Barber; Raj A Persad; Christopher G Eden
Journal:  Rev Urol       Date:  2015

Review 2.  The management of the access tract after percutaneous nephrolithotomy.

Authors:  Tanja Hüsch; Michael Reiter; René Mager; Eva Steiner; Thomas R W Herrmann; Axel Haferkamp; David Schilling
Journal:  World J Urol       Date:  2015-04-23       Impact factor: 4.226

3.  Comparison of outcomes in totally tubeless percutaneous nephrolithotomy according to nephrostomy tract sealing with fibrin versus gelatin matrix: a propensity score matching study.

Authors:  Jung Jun Kim; Yoon Seok Suh; Deok Hyun Han
Journal:  Urolithiasis       Date:  2019-03-14       Impact factor: 3.436

Review 4.  Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis.

Authors:  Cui Yu; Zhou Xu; Wang Long; Liu Longfei; Zeng Feng; Qi Lin; Zu Xiongbing; Chen Hequn
Journal:  Urolithiasis       Date:  2014-07-27       Impact factor: 3.436

5.  The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy: a meta-analysis.

Authors:  Jiawu Wang; Chengyao Zhang; Guangzhong Tan; Bo Yang; Wenkai Chen; Dan Tan
Journal:  Urolithiasis       Date:  2014-09-09       Impact factor: 3.436

Review 6.  Advances in tubeless percutaneous nephrolithotomy and patient selection: an update.

Authors:  Mitra R de Cógáin; Amy E Krambeck
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

7.  Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study.

Authors:  Luigi Cormio; Gaspar Ibarlucea Gonzalez; David Tolley; Mario Sofer; Ahmet Muslumanoglu; Hans-Christoph Klingler; Jens-Uwe Stolzenburg; Jean de la Rosette
Journal:  World J Urol       Date:  2012-07-01       Impact factor: 4.226

Review 8.  SF-36 total score as a single measure of health-related quality of life: Scoping review.

Authors:  Liliane Lins; Fernando Martins Carvalho
Journal:  SAGE Open Med       Date:  2016-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.